文献速递分子诊断临床微生物

基于Ridom SeqSphere+的鲍曼不动杆菌核心基因组多位点序列分型及ARESdb耐药表型预测

Acinetobacter baumannii Genomic Sequence-Based Core Genome Multilocus Sequence Typing Using Ridom SeqSphere+ and Antimicrobial Susceptibility Prediction in ARESdb.
PubMed 文献 · J Clin Microbiol · 2022-07-12

此前PCR/ESI-MS分型与cgMLST在等位基因差异≤9和≤200阈值下分别有78%和94%的菌株相关。基因型与表型药敏在11种常用药物中的分类一致率为89%,微小、重大和极重大错误率分别为8%、11%和1%。

要点

  • cgMLST与PCR/ESI-MS分型在≤9个等位基因差异阈值下相关率为78%,≤200阈值下为94%。
  • ARESdb基因型预测11种常用药物耐药表型的分类一致率为89%。
  • 预测药敏的微小、重大和极重大错误率分别为8%、11%和1%。

核心结论

  • cgMLST工作流可用于鲍曼不动杆菌分型并与PCR/ESI-MS结果相关。
  • ARESdb基因型预测药敏与表型药敏分类一致率为89%。

研究设计与样本

  • 采用临床微生物实验室建立的cgMLST工作流(Ridom SeqSphere+)进行分型。
  • 使用ARESdb平台进行基因组耐药表型预测。

主要发现

  • PCR/ESI-MS与cgMLST在等位基因差异≤9和≤200阈值下分别有78%和94%的菌株相关。
  • 基因型与表型药敏在11种常用药物中的分类一致率为89%。
  • 微小、重大和极重大错误率分别为8%、11%和1%。

关键数值与推荐

  • cgMLST相关阈值:等位基因差异≤9时相关率78%,≤200时相关率94%。
  • 基因型与表型药敏分类一致率89%,微小错误率8%,重大错误率11%,极重大错误率1%。

临床怎么用

  • cgMLST可用于鲍曼不动杆菌暴发调查的分型替代传统方法。
  • ARESdb基因型药敏预测可作为表型药敏的补充参考。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Whole-genome sequencing (WGS) is rapidly replacing traditional typing methods for the investigation of infectious disease outbreaks. Additionally, WGS data are being used to predict phenotypic antimicrobial susceptibility. Acinetobacter baumannii, which is often multidrug-resistant, is a significant culprit in outbreaks in health care settings. A well-characterized collection of A. baumannii was studied using core genome multilocus sequence typing (cgMLST). Seventy-two isolates previously typed by PCR-electrospray ionization mass spectrometry (PCR/ESI-MS) provided by the Antimicrobial Resistance Leadership Group (ARLG) were analyzed using a clinical microbiology laboratory developed workflow for cgMLST with genomic susceptibility prediction performed using the ARESdb platform. Previously performed PCR/ESI-MS correlated with cgMLST using relatedness thresholds of allelic differences of ≤9 and ≤200 allelic differences in 78 and 94% of isolates, respectively. Categorical agreement between genotypic and phenotypic antimicrobial susceptibility across a panel of 11 commonly used drugs was 89%, with minor, major, and very major error rates of 8%, 11%, and 1%, respectively.

来源:J Clin Microbiol,查看原文。版权归原作者所有。

引用

  1. Fida M, Cunningham SA, Beisken S, et al. Acinetobacter baumannii Genomic Sequence-Based Core Genome Multilocus Sequence Typing Using Ridom SeqSphere+ and Antimicrobial Susceptibility Prediction in ARESdb. J Clin Microbiol. 2022. PMID: 35862760. doi:10.1128/jcm.00533-22

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。